The present invention relates to an antiviral composition. The antiviral composition of the invention is applied to textiles to make the textiles virus-resistant before they can be used. The antiviral composition includes an antiviral agent, one or more binding agents and a catalyst or a softener depending upon the utility of the antiviral composition.

Provided is an impregnated pesticide granular composition for soil application comprising: a) a nicotinic acetylcholine receptor competitive modulator or a ryanodine receptor modulator; b) a polar organic solvent having, among Hansen solubility parameters, a dP of 4.5 or larger and 11.0 or smaller, and a dH of 4.5 or larger and 11.0 or smaller; and c) a water-insoluble, oil-absorbing granular carrier having an oil absorption capacity of 1 to 70%, and a particle diameter of 0.2 to 2.0 mm, wherein the composition having a hardness of 0.2 kg or larger. According to the present invention, an impregnated pesticide granular composition for soil application that is capable of demonstrating a stable biological effect can be provided.

Provided is an impregnated pesticide granular composition for soil application comprising: a) a nicotinic acetylcholine receptor competitive modulator or a ryanodine receptor modulator; b) a polar organic solvent having, among Hansen solubility parameters, a dP of 4.5 or larger and 11.0 or smaller, and a dH of 4.5 or larger and 11.0 or smaller; and c) a water-insoluble, oil-absorbing granular carrier having an oil absorption capacity of 1 to 70%, and a particle diameter of 0.2 to 2.0 mm, wherein the composition having a hardness of 0.2 kg or larger. According to the present invention, an impregnated pesticide granular composition for soil application that is capable of demonstrating a stable biological effect can be provided.

The invention relates to a process for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation. The invention further relates to the use of a water soluble source of lithium ions for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation.

The invention relates to a process for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation. The invention further relates to the use of a water soluble source of lithium ions for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation.

The invention relates to a process for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation. The invention further relates to the use of a water soluble source of lithium ions for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation.

A technique for inducing tolerance to environmental stress in a plant is provided. Tolerance to environmental stress in a plant is induced by applying to the plant an abscisic acid-like substance, such as abscisic acid and agonists thereof, in combination with a nitrogen-containing compound, such as amino acids and amino acid derivatives.

In a method of integrating an active pharmaceutical ingredient (API) with a thermoplastic polymer, the thermoplastic polymer and API are into a first feed port of a multi-screw extruder or the thermoplastic polymer is fed into the first feed port of a multi-screw extruder, the thermoplastic polymer is conveyed along the heated multi-screw extruder while heating the thermoplastic polymer to a melt temperature of 160° C.-280° C. prior to the thermoplastic polymer being conveyed past a second feed port and the API is fed into the second feeding port in the heated screw extruder to mix with the melted thermoplastic polymer to generate a compounded mixture containing 85-100% of the starting API content. The compounded mixture is extruded from an outlet of the heated screw extruder and cooled via a cooling device such that the compounded mixture contains 85-100% of the starting API content.

In a method of integrating an active pharmaceutical ingredient (API) with a thermoplastic polymer, the thermoplastic polymer and API are into a first feed port of a multi-screw extruder or the thermoplastic polymer is fed into the first feed port of a multi-screw extruder, the thermoplastic polymer is conveyed along the heated multi-screw extruder while heating the thermoplastic polymer to a melt temperature of 160° C.-280° C. prior to the thermoplastic polymer being conveyed past a second feed port and the API is fed into the second feeding port in the heated screw extruder to mix with the melted thermoplastic polymer to generate a compounded mixture containing 85-100% of the starting API content. The compounded mixture is extruded from an outlet of the heated screw extruder and cooled via a cooling device such that the compounded mixture contains 85-100% of the starting API content.

A multi-use disinfecting cap and method for disinfection and protection of a needleless IV injection port. The disinfecting cap has an upper chamber which contains a sterilizing solution and a low chamber which connects to a needleless IV injection port. The fluid can be manipulated to flow between the two chambers. When in use the cap protects and disinfects a needleless IV injection port when exposed prior to injecting medication into the needleless port and continues to disinfect and protect prior for any subsequent exposures. The cap is re-usable and provides a clear indication of the disinfecting solution and a datable top surface. The multi-use disinfecting cap may be removably clipped to the IV tubing and is shaped to prevent accidental rolling away if dropped.